Disclosure of Directors & Senior Managers Relevant Interest

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
ArborGen Holdings Limited
Date this disclosure made:
2 August 2023
Date of last disclosure:
3 August 2022
Director or senior manager giving disclosure
Full name(s):
Ana Gabriela Monnerat Carvalho
Name of listed issuer:
ArborGen Holdings Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
General Manager, Brazil
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
ARB Ordinary Shares
Nature of the affected relevant interest(s):
Right to acquire restricted share units (RSUs)
convertible into ARB Ordinary Shares, subject to
performance targets and vesting criteria being met
For that relevant interest-
Number held in class before acquisition or disposal:
2021 RSUs (awarded): 88,184
Ordinary Shares: 44,092
Number held in class after acquisition or disposal:Ordinary Shares: 132,276
Current registered holder(s):
Ana Gabriela Monnerat Carvalho
Registered holder(s) once transfers are registered:
Ana Gabriela Monnerat Carvalho
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1

Details of transactions requiring disclosure-
Date of transaction:27 July 2023
Nature of transaction:
Entry into Conditional Restricted Share Unit Agreement
(RSU Agreement) to receive ArborGen RSUs, subject
to the ArborGen group's achievement of certain
financial performance hurdles in accordance with the
ArborGen 2022 LTI Plan.
Any RSUs awarded under the RSU Agreement will
vest as ARB Ordinary Shares in three equal tranches
on three separate vesting dates, provided that the
holder of the RSU remains employed by the ArborGen
group on the applicable vesting date. On 26 July 2022,
the first tranche of 44,092 vested as ARB Ordinary
Shares. On 27 July 2023, the second and third
tranches have all vested as ARB Ordinary Shares due
to the respective senior manager's retirement.
Name of any other party or parties to the transaction (if known):N/A
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily
by converted into a cash value, describe the consideration:
No cash consideration is payable for the RSUs. The
consideration for the RSUs is the services rendered by
the participant over the 2022 LTI Plan period.
Number of financial products to which the transaction related: 88,184 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or
senior managers from trading during any period without written clearance (a closed
period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:N/A
Nature of relevant interest:N/A
For that relevant interest,-
Number held in class:N/A
Current registered holder(s):N/A
For a derivative relevant interest,-
Type of derivative:N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the value
of the underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:

Certification
I, certify that, to the best of my knowledge and belief, the information contained in
this disclosure is correct and that I am duly authorised to make this disclosure by
all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
2 August 2023
Name and title of authorised person:
Sharon Ludher-Chandra Company Secretary